Written by the Nuvirox Research Team
Key points
- Beta-blockers suppress your body's own nighttime melatonin release, which is one documented reason they're linked to insomnia, vivid dreams, and nightmares in some patients.
- A randomized trial found nightly melatonin supplementation improved sleep efficiency and total sleep time in hypertensive patients already taking beta-blockers — but this is a medication-interaction question, not a supplement-aisle decision.
- A large meta-analysis of over 50,000 patients across 258 trials found beta-blockers were not clearly linked to depression, but sleep-related symptoms did emerge as a real, separate effect worth monitoring with your prescriber.
Short answer: yes, beta-blockers are a documented cause of insomnia and vivid or disturbing dreams in a meaningful subset of patients, and the leading mechanism is that certain beta-blockers suppress your body's own melatonin production at night. This is genuinely useful to understand — but because beta-blockers are prescribed for serious cardiovascular conditions and any fix has to work alongside that medication, this is a conversation for your prescribing doctor, not a supplement decision to make on your own.
Why would a blood pressure or heart medication affect sleep at all?
Beta-blockers work by blocking adrenergic beta-receptors, primarily in the heart and blood vessels. Some beta-blockers, particularly the more lipophilic ones like propranolol and metoprolol, are able to cross into the central nervous system. Once there, the leading proposed mechanism is that they suppress the body's nighttime melatonin secretion, which is normally triggered by a beta-adrenergic signal from the sympathetic nervous system to the pineal gland. Beta-blockers can also blunt the normal nighttime dip in blood pressure and heart rate, keeping the body in a slightly more physiologically aroused state that isn't conducive to deep sleep.
Reported sleep-related side effects include insomnia, nightmares, and unusually vivid dreams, occurring in roughly 2% to 4% of patients across studies, with higher rates tied to more lipophilic, brain-penetrant drugs like propranolol compared with less lipophilic ones like atenolol or bisoprolol.
What does the trial evidence on melatonin and beta-blockers actually show?
A randomized, double-blind, placebo-controlled trial at Brigham and Women's Hospital gave 16 hypertensive patients already taking atenolol or metoprolol either nightly melatonin (2.5 mg) or placebo for three weeks, with sleep measured objectively by polysomnography. Compared with placebo, melatonin increased total sleep time by about 36 minutes, improved sleep efficiency by roughly 7.6%, and shortened the time it took participants to reach stable sleep by about 14 minutes. Notably, the improvement didn't fade with three weeks of continued use, and there was no rebound sleep disturbance when melatonin was stopped (Scheer et al., 2012).
That's a genuinely encouraging finding for this specific population. But it's a small trial — 16 people — studying one particular intervention layered on top of an existing cardiovascular medication regimen under close medical supervision. It is not a green light for self-directed supplementation.
Is this just "in your head," or is it a real, measurable effect?
It's real and it's been measured directly. Early polysomnography work found that atenolol alone increased nighttime awakenings and reduced slow-wave and REM sleep compared with placebo. More recent systematic review work has specifically found that beta-blockers are associated with a higher (though not always statistically significant across all comparisons) risk of nightmares relative to other blood pressure medications, and that certain beta-blockers prolong REM latency and alter REM sleep distribution — plausible contributors to more vivid, disturbing dreams (Eddin et al., 2025).
The honest counterweight: a large meta-analysis pooling data from over 50,000 patients across 258 randomized trials found that beta-blockers were not clearly linked to depression as a class effect, despite decades of assumption that they were. Sleep-related symptoms like unusual dreams and insomnia did still emerge in that same analysis as a real signal — so the sleep effect appears more consistently supported than some of the other psychiatric side effects historically blamed on this drug class.
A note before the product section
Beta-blockers are prescribed for conditions where stopping, switching, or adjusting the medication without medical supervision carries real cardiovascular risk — including after a heart attack or stroke, where research suggests patients may already be more vulnerable to psychological complications. Melatonin and other sleep interventions can interact with how well the underlying condition is managed, and the right next step is a conversation with the prescribing doctor, not a self-directed supplement change. Because of that, we're not including a product recommendation in this article — the responsible path here runs through your physician.
What are the realistic options, according to the research?
Three things come up consistently in the literature, all of which are decisions for your doctor to weigh: switching to a less lipophilic beta-blocker (such as atenolol or bisoprolol) if a more brain-penetrant one like propranolol or metoprolol seems to be the culprit; adjusting the timing of the dose; and, as the Brigham trial suggests, supervised melatonin supplementation timed with the medication schedule. None of these are safely done by simply picking up a supplement at random — dose, timing relative to the medication, and interaction with the underlying cardiovascular condition all matter.
What this article won't tell you
It won't tell you to stop or adjust your beta-blocker, and it won't recommend a specific over-the-counter sleep aid to combine with it on your own. If beta-blocker-related insomnia or nightmares are affecting your quality of life, that's a legitimate, well-documented issue worth raising directly with the doctor who prescribed the medication — bring the specific symptoms (trouble falling asleep, waking through the night, disturbing dreams) and ask whether a formulation change or a supervised approach to melatonin makes sense for your situation.
Frequently asked questions
Which beta-blockers are most likely to cause sleep problems?
The more lipophilic (fat-soluble, brain-penetrant) beta-blockers — propranolol and metoprolol are the most frequently cited — appear more associated with insomnia and nightmares than less lipophilic ones like atenolol or bisoprolol, based on cohort data.
Can I just take melatonin on my own if I'm on a beta-blocker?
This is exactly the kind of question to bring to your prescribing doctor rather than decide independently. The supervised trial that found benefit used a specific dose and monitored patients closely; self-directed supplementation alongside a cardiovascular medication isn't the same situation.
Are these sleep effects permanent?
The research doesn't suggest permanence — the melatonin trial found improvements sustained over three weeks with no rebound disturbance after stopping, which points toward a manageable, monitorable effect rather than a fixed one.
Could my nightmares be caused by something else entirely?
Possibly. If you're also taking other medications, or if nightmares are frequent regardless of medication, it's worth mentioning the full picture to your doctor rather than assuming a single cause.
Is beta-blocker insomnia similar to other medication- or substance-withdrawal insomnia?
It shares the general pattern of a medication or its discontinuation disrupting sleep architecture, though the underlying mechanism differs — see our piece on opioid withdrawal insomnia for a very different but similarly medically-supervised example.
The bottom line
Beta-blockers have a real, mechanistically plausible, and trial-documented link to insomnia and disturbed dreaming, largely through melatonin suppression and altered REM sleep. There's encouraging small-trial evidence that supervised melatonin supplementation can help in this specific population — notably including patients recovering from a cardiovascular event, where sleep disturbance is separately common and worth screening for. But this sits squarely in medication-management territory — the right first move is a conversation with your prescribing physician, not a product decision. If your sleep issues turn out to be unrelated to the medication, resources like our guide to sleeping better naturally or our breakdown of melatonin dosing may be a useful next stop once your doctor has ruled the medication in or out as the cause.
References
- Scheer FAJL, Morris CJ, Garcia JI, et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395-1402. DOI: 10.5665/sleep.2122. PMID: 23024438.
- Eddin RN, et al. β-Blockers and risk of neuropsychiatric disorders: A systematic review and meta-analysis. Br J Clin Pharmacol. 2025. DOI: 10.1111/bcp.16361.
- Riemann D, et al. Vivid dreams and nightmares as an adverse effect of beta-blockers in migraine prophylaxis. PMCID: PMC12771627.
- Kreutz R, et al. Beta-blockers not likely to cause depression yet may contribute to sleep disturbances. American Heart Association news summary of neuropsychiatric meta-analysis, 2021.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.